x
Filter:
Filters applied
- Guidelines
- Halperin, Jonathan LRemove Halperin, Jonathan L filter
- Creager, Mark ARemove Creager, Mark A filter
- Buller, Christopher ERemove Buller, Christopher E filter
Author
- Albert, Nancy M1
- Anderson, Jeffrey L1
- Bonow, Robert O1
- Dearani, Joseph A1
- Ettinger, Steven M1
- Fifer, Michael A1
- Gersh, Bernard J1
- Guyton, Robert A1
- Hochman, Judith S1
- Jacobs, Alice K1
- Krumholz, Harlan M1
- Kushner, Frederick G1
- Link, Mark S1
- Maron, Barry J1
- Naidu, Srihari S1
- Nishimura, Rick A1
- Ohman, E Magnus1
- Ommen, Steve R1
- Page, Richard L1
- Rakowski, Harry1
- Seidman, Christine E1
- Smith, Sidney C Jr1
Guidelines
1 Results
- Clinical guidelineOpen Access
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
The Journal of Thoracic and Cardiovascular SurgeryVol. 142Issue 6e153–e203Published in issue: December, 2011- Writing Committee Members:∗
- Bernard J. Gersh
- Barry J. Maron
- Robert O. Bonow
- Joseph A. Dearani
- Michael A. Fifer
- and others
- ACCF/AHA Task Force Members
- Alice K. Jacobs
- Sidney C. Smith Jr.
- Jeffrey L. Anderson
- Nancy M. Albert
- Christopher E. Buller
- and others
Cited in Scopus: 206It is essential that the medical profession play a central role in critically evaluating the evidence related to drugs, devices, and procedures for the detection, management, or prevention of disease. Properly applied, rigorous, expert analysis of the available data documenting absolute and relative benefits and risks of these therapies and procedures can improve the effectiveness of care, optimize patient outcomes, and favorably fnect the cost of care by focusing resources on the most effective strategies.